BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases. Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing? Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies. We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

Who is BlueRock? BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases. The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture,



and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology.

What Are We Doing? Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit. We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and agile culture, and are steadfast in the commitment to advance cutting‑edge cellular therapies to impact patients’ lives.

Description of Position: The Analytical and Quality Control (A&QC;) Senior Analyst – Compliance will provide support for a wide variety of A&QC; Compliance requirements for the laboratory activities facilitating testing of cell‑based therapeutics destined for human clinical trials. The Senior Analyst will be one of the key contributors in driving all aspects of the QC laboratory compliance through appropriate quality systems. The candidate will report to the Associate Director,



A&QC; and work closely with all subgroups (i.e., Testing, EM, Ops etc.) within A&QC; to provide support in quality aspects. The Senior Analyst will be instrumental in ensuring compliance within the laboratory through issues, change controls, deviations, lab investigations, CAPAs, change actions and audit support. The candidate will also support management of documentation. Duties include control of the GMP documentation and data generated, aiding in the quality and compliance of the laboratory operations and data integrity for testing in the QC lab to meet applicable U.
S., Canadian and global standards.

Responsibilities

- Work closely with Quality Assurance (QA) and A&QC; assay SMEs or process owners to support management of QC‑related quality records in the electronic Quality Management System (eQMS), i.e., issues, change controls, deviations, lab investigations, CAPAs, change actions and audit activities relevant to testing, equipment, and processes etc.
- Handle routine quality records independently and have the capability to advance the ones with moderate complexity under minimal supervision.
- Be involved in drafting and pushing quality records for on‑time closure and/or guiding the quality record owners (i.e., QC assay SMEs) to achieve.
- Track and update the progress of all quality records pertaining to QC at regular basis.
- Participate workflow improvement within eQMS as needed.
- Support authoring and review of SOPs related to QC activities and provide QC input for cross‑functional SOPs relating to general GMP compliance.
- Support management of QC documentation workflow, including GDP compliance of laboratory records.
- Triage supplier chang

📌 Senior Analyst, Analytical and Quality Control (Toronto)
🏢 BlueRock Therapeutics
📍 Toronto